[Clinical cooperative testing of the antidepressive agent noxiptilin in the University Neuroclinics of Kiel, Mainz and Marburg].
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003986:Dibenzocycloheptenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D005860:Germany, West; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008297:Male; D009497:Neurotic Disorders / Q000188:drug therapy; D010259:Paranoid Disorders / Q000188:drug therapy; D010554:Personality Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D014555:Urination Disorders / Q000139:chemically induced
D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes
Klinische Gemeinschftsprüfung des Antidepressivums Noxiptilin in den Universitäts-Nervenkliniken Kile, Mainz und Marburg.